Back to Top Skip to main content Skip to sub-navigation

MHS operational innovations continue in battle against COVID-19

Two medical personnel, wearing full PPE, in an operating room Army Maj. (Dr.) Douglas Ruhl, a surgeon at Madigan Army Medical Center, at Joint Base Lewis-McChord, Washington, uses the COVID-19 airway management isolation chamber (CAMIC) to perform a mastoidectomy, which removes a growth behind the eardrum. This procedure requires drilling into the skull, creating bone dust and aerosolized droplets. (Photo courtesy of Douglas Ruhl.)

Recommended Content:

Coronavirus | Research and Innovation | Innovation | Technology | COVID-19 Vaccine Toolkit

Operational medicine performed by deployed military medical personnel has always driven innovation, and this was more important than ever in responding to the COVID-19 pandemic.

Military Health System innovations in 2020 include a new registry for real-time COVID-19 data and a system to free up hospital beds and protect patients from the disease. Service Members also developed inexpensive ventilator designs and adapted safer ways to transport and perform surgical procedures on COVID-19 patients.

Meeting the need for real-time COVID-19 data, the Joint Trauma System (JTS) developed a global COVID-19 registry to track patients and their outcomes.

The COVID-19 registry exceeded 90,000 patients in the Department of Defense as of the first week of December, said JTS Chief, Air Force Col. (Dr.) Stacy Shackelford. The registry began collecting real-time COVID-19 data in May.

The JTS is conducting detailed patient chart analyses of the COVID-19 registry to look at items such as deaths within the MHS and other COVID-19 subpopulations of interest, Shackelford said. So far, 3,200 charts have been analyzed.

“In general, the registry has an important capability to look at treatments and outcomes. That’s our number one goal,” she said. For example, the registry compares outcomes of COVID-19 available treatments including convalescent plasma, steroids and remdesivir.

“Our number two goal is long-term tracking of patients and links to other outcomes,” Shackelford said.

Image of a hospital bed with a platform with holes designed for a patient lying face down.
A pronating shelf (foreground) was designed to improve a COVID-19 patient’s ability to breathe through a ventilator while face down in an ICU bed. The shelf, with cutouts for a patient’s face, was prototyped at Keesler Air Force Base, Mississippi. (Photo courtesy of Keesler Air Force Base.)

The registry could track active duty personnel’s annual physical fitness tests for lingering COVID-19-related results, or the annual periodic health assessment, to which the JTS plans to add questions related to mental health and the COVID-19 pandemic, she added. Additionally, “the registry is tracking genetics testing down to the granular level so we can tap into a look at clinical outcomes that would be available to other scientists.”

Members also developed innovative ways to modify the care environment to meet the needs of COVID-19 patients, like a pronating shelf and a low-cost ventilator.

The pronating shelf, prototyped at Keesler Air Force Base in Mississippi, helps COVID-19 patients breathe while lying prone (face down) for hours while on ventilators. Previously, patients in this position using a ventilator had their head and neck turned at a difficult angle, which often obstructed airways. The Keesler pronate shelf supports the head while keeping it in proper position to use the ventilator.

The Naval Surface Warfare Center Panama City Division (NSWC PCD) in Florida developed low-cost, easily-assembled ventilators to expand access to these life-saving devices. The ventilators were designed as part of a challenge across hundreds of submissions and entered the prototype phase.

The challenge came during the initial surge in the pandemic, and the Navy ventilators were intended as stop-gap measures should ventilator supplies have dwindled across the nation or if COVID-19 numbers surged beyond U.S. hospitals’ capacities. These units were tested at the Walter Reed National Military Medical Center (WRNMMC) in Bethesda, Maryland.

Military medical personnel, wearing masks and gloves, loading a COVID-19 patient into an isolated containment chamber
Airmen assigned to the 313th Expeditionary Operations Support Squadron transfer a COVID-19 patient following the first-ever operational use of the Negatively Pressurized Conex to transport 12 patients aboard a C-17 Globemaster III aircraft at Ramstein Air Base, Germany on July 1, 2020 to receive higher level of care at the Landstuhl Regional Medical Center, Germany. The NPC is the latest isolated containment chamber developed to transport up to 28 individuals with infectious diseases. (Photo by Air Force Airman 1st Class John Wright.)

The first commercially produced version of the Navy’s PRE-Vent is being built for a final round of U.S. Food and Drug Administration testing that aims to prove the design can be manufactured from biocompatible materials and pass stringent agency guidelines for emergency use authorization. The build should be completed this January and then sent for evaluation to the FDA.

The ventilators can be assembled from materials commonly found at hardware stores with a cost of $300 to $600, significantly less than commercially available ventilators. The ventilators can be built on the fly to address patients’ breathing assistance needs in field hospital settings.

Transporting COVID-19 patients by air led to another innovation to protect patients, providers and aircrew during flight.

The Air Force’s Negatively Pressurized Conex (NPC) allows for the safe air transport of patients exposed to COVID-19 without risking the aircrew’s health by surrounding patients within a negatively pressurized containment system. This system allows for the transport of up to 24 infected personnel seated or up to eight stretchers. Thus far during this global pandemic, the Air Force has successfully completed some 65 COVID-19 aeromedical evacuation missions.

The need to protect health care workers from COVID-19 led to the development of the COVID-19 Airway Management Isolation Chamber, or CAMIC. CAMIC is a an adjunct personal protective equipment (PPE) barrier device constructed by placing a large clear plastic bag on a PVC piping box frame over the head, neck and shoulders of patients. When used with other PPE, CAMIC protects health care personnel by providing a physical barrier to aerosolized droplets from patients with COVID-19 by capturing and removing viral particles emitted by the patient. CAMIC was conceived, designed, built and tested by the Army’s Telemedicine and Advanced Technology Research Center.

In a similar vein, researchers from the U.S. Army Combat Capabilities Development Command’s Army Research Laboratory and the University of Pittsburgh Medical Center created an individual biocontainment unit that uses negative pressure to suction the air from around a patient and filter out viral particles.

While 2020 proved to be an active year for operational medical innovations because of the global pandemic, the MHS continuously develops creative protocols, systems or devices that can be used in austere environments where energy sources are limited and where the military is deployed.

You also may be interested in...

DHA IPM 18-011: Video Network Center (VNC) Endpoint Standards

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g): - Provides guidance for video network endpoint standards required for sites to connect to the Defense Health Agency (DHA) VNC network. These standards will help ensure security compliance, efficiency, and best practices are maintained across the DHA network. Meeting certification requirements brings many benefits, including: increased assurances of a successful video teleconference (VTC) experience, full access to bridge and point-to-point calls, and access to peer video networks, including the Department of Veterans Affairs, academia, and industry partners. Compliance with stated standards does not preclude users connecting to other DoD approved networks. - This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-011
  • Date: 9/20/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

DHA PI 3201.05: Technology Transfer (T2) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI) based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (t), establishes responsibilities, procedures, and guidance for the Defense Health Agency’s (DHA) T2 program.

  • Identification #: 3201.05
  • Date: 6/20/2019
  • Type: DHA Procedural Instruction
  • Topics: Technology

DHA IPM 18-018: Physical Custody and Control of the DoD Health Record

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): • Establishes the Defense Health Agency’s (DHA) procedures for the physical custody and control of DoD Health Records at all DoD Military Treatment Facilities (MTFs) and the management, monitoring, review, and evaluation of DoD Health Record availability at MTFs. • This DHA-IPM is effective immediately and will expire effective 12 months from the date of issue. It must be incorporated into the forthcoming DHA-Procedural Instruction, “Health Records Management”.

DHA IPM 18-017: Military Health System (MHS) Information Technology (IT) Investment Management Framework

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (v), establishes Defense Health Agency’s (DHA) procedures to: • Establish the overarching guidance to implement policies and procedures for managing DHA Deputy Assistant Director, Information Operations (DAD IO)/J-6 Defense Health Program (DHP) IT resources. The DHA Investment Management Framework is used as an enabler for MHS leadership to make informed transparent financial decisions associated with the DHA DAD IO/J-6 systems, services, and capabilities and will continue to be used in the foreseeable future. • Provide full and total awareness of all IT across the enterprise ensuring all MHS healthcare-related IT investments are accounted for and integrated both operationally and financially. This includes all IT systems, applications, and devices and all their funding identified to manage a coherent and integrated healthcare capability across the enterprise. • Provide and supersede guidance and instructions previously provided through the Services. As Military Medical Treatment Facilities (MTFs) transition to DHA management and responsibility, procedures in this DHA-IPM will supersede IT systems guidance and instructions previously provided through the Services; including IT systems in all MTFs, clinics, and enterprise services provided to Other Lines-of-Business (OLB), such as training and research, etc. In addition, it supports a coherent and comprehensive catalog of IT capability investments encompassing all IT used to support the MHS mission. • Require that all funding sources, type and Budget Activity Group (BAG), purchasing or supporting any IT must be identified for inclusion in the DHA portfolio of IT capability investments. • Provide superseding guidance and instruction, through this DHA-IPM until a DHA-Procedural Instruction is issued previously provided by the Services in References (w) through (ad), for the MTFs as they are transitioned to DHA management and responsibility. • This DHA-IPM is effective immediately and it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-017
  • Date: 11/6/2018
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA PI 8140.01: Acceptable Use of Defense Health Agency Information Technology (IT) (Updated)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (m), establishes the Defense Health Agency’s (DHA) procedures for acceptable use of DHA IT by authorized and privileged users.

  • Identification #: DHA PI 8140.01
  • Date: 10/16/2018
  • Type: DHA Procedural Instruction
  • Topics: Technology

Waiver of Restrictive Licensure and Privileging Procedures to Facilitate the Expansion of Telemedicine Services in the Military Health System 12-010

Policy

In order to facilitate the expansion of telemedicine services in the Military Health System, this memorandum waives selective provisions of Department of Defense 602S.13-R, "Clinical Quality Assurance in the Military Health System," June 11 , 2004. This waiver is conditioned on the specific provisions of this memorandum, and shall remain in effect, unless modified or revoked, until the cancellation and reissuance of DoD 602S.13-R, or the issuance of a Department of Defense Instruction for or including telemedicine.

MHS Enterprise Architecture Signed Memo and Guide 20120730

Policy

Announcement of the release of the Military Health System (MHS) Enterprise Architecture (EA) Guide. The guide supports the MHS CIO’s responsibilities for development and maintenance of EA, which complies with the Department of Defense’s responsibilities under the Clinger-Cohen Act of 1996, Public Law 104-106.

  • Identification #: 00-memo-2012-07-30
  • Date: 7/30/2012
  • Type: Memorandums
  • Topics: Technology

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Standard Enterprise Architecture Requirements for Acquiring Information Management/Information Technology Products and Services

Policy

The Military Health System (MHS) Information Management/Information Technology (IM/IT) Strategic Plan established enterprise-wide interoperability and common architecture goals for MHS 1M/IT products and services that promote agility and interoperability within MHS and externally with Federal and industry partners.

  • Identification #: 00-memo-2012-06-19
  • Date: 6/19/2012
  • Type: Memorandums
  • Topics: Technology

MHS Cloud First Adoption Directive and Policy Guidance Signed Memo and Attachment

Policy

The National Defense Authorization Act for Fiscal Year (FY) 2012 mandates that the Department of Defense (DoD) and its agencies develop a strategy to migrate to using Cloud computing services. Against this backdrop, DoD released an IT Enterprise Strategy and Roadmap plan in September 2011 developed by the DoD CIO, Teri Takai. This memorandum is consistent with Federal and DoD strategies, directives, and plans as they relate to implementation of a Military Health System (MHS) Cloud First policy aligning with the MHS mission

  • Identification #: 00-memo-2012-05-22
  • Date: 5/22/2012
  • Type: Memorandums
  • Topics: Technology

Planning for the Reform of the Governance of the Military Health System

Policy
  • Identification #: N/A
  • Date: 3/2/2012
  • Type: Guidelines
  • Topics: Innovation
<< < 1 2 > >> 
Showing results 16 - 27 Page 2 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.